Thailand collaborates with US Vaccine Research Centre on tuberculosis vaccines

[webfact]

PHOTO: Unsplash

 

by Mitch Connor

Thailand’s National Vaccine Institute (NVI) has formed a partnership with the US Vaccine Research Centre (VRC) to develop vaccines against tuberculosis, including those utilising Messenger RNA (mRNA) technology. The collaboration was announced following a visit by senior officials from Thailand’s Public Health Ministry to the VRC on April 20.

 

The VRC is a leading global organisation in vaccine research and has successfully developed 15 vaccine types for various diseases, including influenza, Covid-19, Ebola, Zika fever, and tuberculosis. The visitors were greeted by Richard Koup, the VRC deputy director, within the framework of the National Institute of Allergy and Infectious Diseases.

According to the Thai government, the country’s Department of Medical Sciences and NVI are determined to work with the US VRC to create a new tuberculosis vaccine. Thailand has planned to research four types of tuberculosis and mRNA vaccines, with the aim of achieving vaccine security in the country through the production of locally-researched mRNA vaccines.

 

Full story: https://thethaiger.com/coronavirus/thailand-collaborates-with-us-vaccine-research-centre-on-tuberculosis-vaccines

 

-- © Copyright Thaiger 2023-05-02

 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

The most versatile and flexible rental investment and holiday home solution in Thailand - click for more information.